Genetics of Parkinson's disease

Human Molecular Genetics

Volumn 6, Issue 10 REV. ISS., 1997, Pages 1687-1691

  Nussbaum, Robert L ^a   Polymeropoulos, Mihael H ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MEMBRANE PROTEIN; MUTANT PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; AUTOSOMAL DOMINANT INHERITANCE; CELL DEATH; CELL INCLUSION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GANGLION; GENE MUTATION; GENETIC EPIDEMIOLOGY; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; INHERITANCE; LEWY BODY; MISSENSE MUTATION; NEUROPATHOLOGY; OLFACTORY TRACT; PARKINSON DISEASE; PHENOTYPE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RISK FACTOR; SENILE PLAQUE; SUBSTANTIA NIGRA;

ALPHA-SYNUCLEIN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 4; FAMILY; HUMANS; LINKAGE (GENETICS); NERVE TISSUE PROTEINS; PARKINSON DISEASE; POINT MUTATION; RISK FACTORS; SYNUCLEINS;

EID: 0030768929     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.10.1687     Document Type: Article

References (12)

1. Parkinson, J. (1817) An Essay on the Shaking Palsy. Sherwood, Neely and Jones. London.
2. Schapira, A.H. (1995) Nuclear and mitochondrial genetics in Parkinson's diseased. Med. Genet., 32, 411-414.
3. Duvoison, R.C., Eldridge, R., Williams, S., Nutt, J. and Calne, D. (1981) Twin study of Parkinson's disease. Neurology, 31, 77-80.
4. Ward, C.D., Duvoisin, R.C., Ince, S.E., Nutt, J.D., Eldridge, R. and Calne, D.B. (1983) Parkinson's Disease in 65 pairs of twins and in a set of quadruplets. Neurology, 33, 815-824.
5. Eldridge, R. and Ince, S.E. (1984) The low concordance rate for Parkinson's Disease in Twins. Neurology, 34, 1354-1356.
6. Ward, C.D., Duvoisin, R.C., Ince, S.E., Nutt, J.D., Eldridge, R., Calne, D.B. and Dambrosia, J. (1984) Parkinson's Disease in Twins. Adv. Neurol., 40, 341-344.
7. Poskanzer, D.C. and Schwab, R.S. (1961) Studies in the epidemiology of Parkinson's disease predicting its disappearance as a major clinical entity by 1980. Trans. Am. Neurol. Assoc., 86, 234-245.
8. Davis, G.D., Williams, A.C., Markey, S.P., Ebert, M.H., Caine, F.D., Reichert, CM. and Kopin, I.J. (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psych. Res., 1, 249-254.
9. Langston, W., Ballard, P., Tetrud, J.W. and Irwin, I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science, 219, 979-980.
10. Tipton, K.F. and Singer, T.P. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem., 61, 1191-1206.
11. Vieregge, P. (1994) Genetic factors in the etiology of idiopathic Parkinson's disease. J. Neural. Transm. Park. Dis. Dement. Sect., 8, 1-37.
12. Duvoisin, R.C. (1996) Recent advances in the genetics of Parkinson's disease. Adv. Neurol., 69, 33-40.